|
Re: Give us just one or two NR’s - money, partners & timeframe
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 10:06AM
|
|
Re: RVX on local Calgary CTV at 5 and 6pm on 11 March
|
6
|
Resverlogix Corp.
|
Mar 12, 2021 10:26AM
|
|
On Yahoo
|
6
|
Resverlogix Corp.
|
Oct 31, 2019 01:33PM
|
|
Not out of the woods yet with COVID-19
|
6
|
Resverlogix Corp.
|
Feb 18, 2022 07:48AM
|
|
Re: Don's latest presentation - Pfizer's SGLT2 is Steglatro (Ertugliflozin)
|
6
|
Resverlogix Corp.
|
Sep 23, 2020 08:24AM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
6
|
Resverlogix Corp.
|
Jan 18, 2022 09:52AM
|
|
57th ERA-EDTA Congress Abstracts
|
6
|
Resverlogix Corp.
|
Jun 08, 2020 05:04AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 05:37AM
|
|
Zenith-Oncology Pipeline
|
6
|
Zenith Epigenetics
|
Mar 16, 2021 08:18AM
|
|
Re: Congratulations To.....
|
6
|
Resverlogix Corp.
|
Dec 11, 2019 05:22AM
|
|
Re: great,good,bad,ugly or so so??
|
6
|
Resverlogix Corp.
|
May 19, 2022 07:18AM
|
|
Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19
|
7
|
Resverlogix Corp.
|
Oct 12, 2021 04:46PM
|
|
Re: Forward looking statements...
|
7
|
Resverlogix Corp.
|
Feb 05, 2021 09:10AM
|
|
Re: Kausik Ray tweeted this this morning
|
7
|
Resverlogix Corp.
|
Aug 18, 2022 07:37AM
|
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
7
|
Resverlogix Corp.
|
Oct 26, 2020 02:04PM
|
|
Re: BRD2 involvement in Covid19
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 10:06PM
|
|
Re: To good to be true?
|
7
|
Resverlogix Corp.
|
Oct 30, 2021 10:34AM
|
|
Re: December 22, 2020.
|
7
|
Resverlogix Corp.
|
Oct 08, 2020 06:31PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 10:19AM
|
|
Q1- March 31, 2022 on SEDAR
|
7
|
Resverlogix Corp.
|
May 14, 2022 11:07AM
|
